EP Patent

EP1595936B1 — Composition for external use

Assigned to Ito Shinobu · Expires 2011-10-19 · 15y expired

What this patent protects

As a technical means of enabling the application of a fullerene and an analogue thereof in various fields relating to biocompatibility to achieve a novel function, in particular as a means of applying the same to a cosmetic product, a formulated skin preparation for external use …

USPTO Abstract

As a technical means of enabling the application of a fullerene and an analogue thereof in various fields relating to biocompatibility to achieve a novel function, in particular as a means of applying the same to a cosmetic product, a formulated skin preparation for external use or the like, an antioxidative composition comprising as an active ingredient at least one kind of a fullerene, a fullerene-containing oxygen derivative and the fullerene and the fullerene-containing oxygen derivative modified with or clathrated in an organic compound is prepared.

Drugs covered by this patent

Patent Metadata

Patent number
EP1595936B1
Jurisdiction
EP
Classification
—
Expires
2011-10-19
Drug substance claim
No
Drug product claim
No
Assignee
Ito Shinobu
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.